Indonesia may have again used the chemical weapon White Phosphorus on indigenous West Papuans in Kiwirok. I am calling for an urgent international investigation into these very serious allegations.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Copyright 2025 The Associated Press. All Rights Reserved. Rescuers have retrieved two more bodies as they resumed their search for people missing after floods and ...
Environmental groups are claiming victory after Mitsubishi Chemical Group dropped plans for a $1.3 billion plant in the heart of Louisiana’s industrial corridor. In the works for more than a ...
Heavy seasonal rain from about October to March frequently causes flooding and landslides in Indonesia, an archipelago of 17,000 islands where millions of people live in mountainous areas or near ...
Copyright 2025 The Associated Press. All Rights Reserved. In this photo released by Indonesia’s National Disaster Management Agency (BNPB), rescuers carry the body ...
(RTTNews) - Investment firm Bain Capital is in talks to acquire Mitsubishi Tanabe Pharma Corp., affiliated to Japan's Mitsubishi Chemical Group (MTLHF.PK), in a potential deal, reports said citing ...
At least 16 people have been killed and 10 injured as a landslide struck Indonesia’s Central Java province, government authorities said. The landslide in the city of Pekalongan was triggered by ...
TOKYO/HONG KONG (Reuters) -Japan's Mitsubishi Chemical Group has picked U.S. investment fund Bain Capital as the preferred bidder for its pharmaceutical subsidiary, Tanabe Mitsubishi Pharma ...
TOKYO -- Japan's Mitsubishi Chemical Group has granted a first-refusal right to U.S. investment fund Bain Capital for the purchase of its pharmaceutical subsidiary Mitsubishi Tanabe Pharma ...
Mitsubishi Chemical Group is stepping up its efforts to streamline operations by entering negotiations with U.S. investment fund Bain Capital to sell its pharmaceutical arm, Mitsubishi Tanabe Pharma.